[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100379010":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":44,"responsibleParty":177,"collaborators":180,"id":201,"slug":202,"hasResults":203,"nctId":204,"briefTitle":205,"officialTitle":206,"acronym":207,"eligibilityCriteria":208,"healthyVolunteers":203,"sex":209,"minAge":210,"maxAge":211,"enrollmentInfo":212,"targetDuration":26,"studyType":215,"phases":216,"briefSummary":218,"conditions":219,"keywords":221,"overallStatus":47,"whyStopped":26,"lastUpdateSubmitDate":224,"lastUpdatePostDateStruct":225,"startDateStruct":228,"completionDateStruct":230,"leadSponsor":232,"locationsCount":233},{"fullName":5,"class":6},"National Cancer Center, Korea","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Aspirin","ACTIVE_COMPARATOR","Enteric coated aspirin",[13],"Drug: Aspirin 100mg",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Enteric coated aspirin placebo",[19],"Drug: Placebo oral tablet",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Aspirin 100mg","Daily aspirin 100 mg for 5 years",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Placebo oral tablet","Daily placebo for 5 years",[15],[32],{"name":33,"affiliation":5,"role":34},"Il Ju Choi, M.D., Ph.D.","STUDY_DIRECTOR",[36,40],{"name":33,"role":37,"phone":38,"phoneExt":26,"email":39},"CONTACT","+82-31-920-2282","cij1224@ncc.re.kr",{"name":41,"role":37,"phone":42,"phoneExt":26,"email":43},"Young-Il Kim, MD","+82-31-920-1712","11996@ncc.re.kr",[45,63,74,88,102,114,128,142,156,167],{"facility":46,"status":47,"city":48,"state":26,"zip":49,"country":50,"countryCode":26,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"Pusan National University Hospital","RECRUITING","Busan","49241","South Korea",{"type":52,"coordinates":53},"Point",[54,55],129.03004,35.10168,{"lat":55,"lon":54},[58,61],{"name":59,"role":37,"phone":26,"phoneExt":26,"email":60},"Gwang Ha Kim, M.D., Ph.D.","doc0224@pusan.ac.kr",{"name":59,"role":62,"phone":26,"phoneExt":26,"email":26},"PRINCIPAL_INVESTIGATOR",{"facility":64,"status":47,"city":48,"state":26,"zip":65,"country":50,"countryCode":26,"cosmosGeoPoint":66,"geoPoint":68,"contacts":69},"Kosin University Gospel Hospital","49267",{"type":52,"coordinates":67},[54,55],{"lat":55,"lon":54},[70,73],{"name":71,"role":37,"phone":26,"phoneExt":26,"email":72},"Moo In Park, M.D., Ph.D.","gimipark2003@naver.com",{"name":71,"role":62,"phone":26,"phoneExt":26,"email":26},{"facility":75,"status":47,"city":76,"state":26,"zip":77,"country":50,"countryCode":26,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"Hallym University Chuncheon Sacred Heart Hospital","Chuncheon","24253",{"type":52,"coordinates":79},[80,81],127.73417,37.87472,{"lat":81,"lon":80},[84,87],{"name":85,"role":37,"phone":26,"phoneExt":26,"email":86},"Gwang Ho Baik, M.D.","baikgh@hallym.or.kr",{"name":85,"role":62,"phone":26,"phoneExt":26,"email":26},{"facility":89,"status":47,"city":90,"state":26,"zip":91,"country":50,"countryCode":26,"cosmosGeoPoint":92,"geoPoint":96,"contacts":97},"Kyungpook National University Chilgok Hospital","Daegu","41404",{"type":52,"coordinates":93},[94,95],128.59111,35.87028,{"lat":95,"lon":94},[98,101],{"name":99,"role":37,"phone":26,"phoneExt":26,"email":100},"Seong Woo Jeon, M.D., Ph.D.","sw-jeon@hanmail.net",{"name":99,"role":62,"phone":26,"phoneExt":26,"email":26},{"facility":103,"status":47,"city":104,"state":26,"zip":105,"country":50,"countryCode":26,"cosmosGeoPoint":106,"geoPoint":110,"contacts":111},"National Cancer Center","Goyang","10408",{"type":52,"coordinates":107},[108,109],127.19731,36.21689,{"lat":109,"lon":108},[112,113],{"name":33,"role":37,"phone":26,"phoneExt":26,"email":39},{"name":33,"role":62,"phone":26,"phoneExt":26,"email":26},{"facility":115,"status":47,"city":116,"state":26,"zip":117,"country":50,"countryCode":26,"cosmosGeoPoint":118,"geoPoint":122,"contacts":123},"Chonnam National University Hospital","Gwangju","61469",{"type":52,"coordinates":119},[120,121],126.91556,35.15472,{"lat":121,"lon":120},[124,127],{"name":125,"role":37,"phone":26,"phoneExt":26,"email":126},"Seon-Young Park, M.D., Ph.D.","drpsy@naver.com",{"name":125,"role":62,"phone":26,"phoneExt":26,"email":26},{"facility":129,"status":47,"city":130,"state":26,"zip":131,"country":50,"countryCode":26,"cosmosGeoPoint":132,"geoPoint":136,"contacts":137},"Incheon St.Mary's Hospital\u002FThe Catholic University","Incheon","21431",{"type":52,"coordinates":133},[134,135],126.70515,37.45646,{"lat":135,"lon":134},[138,141],{"name":139,"role":37,"phone":26,"phoneExt":26,"email":140},"Byung-Wook Kim, M.D.,Ph.D.","gastro@catholic.ac.kr",{"name":139,"role":62,"phone":26,"phoneExt":26,"email":26},{"facility":143,"status":47,"city":144,"state":26,"zip":145,"country":50,"countryCode":26,"cosmosGeoPoint":146,"geoPoint":150,"contacts":151},"Chung-Ang University Hospital","Seoul","06973",{"type":52,"coordinates":147},[148,149],126.9784,37.566,{"lat":149,"lon":148},[152,155],{"name":153,"role":37,"phone":26,"phoneExt":26,"email":154},"Jae Gyu Kim, M.D., Ph.D.","jgkimd@cau.ac.kr",{"name":153,"role":62,"phone":26,"phoneExt":26,"email":26},{"facility":157,"status":47,"city":144,"state":26,"zip":158,"country":50,"countryCode":26,"cosmosGeoPoint":159,"geoPoint":161,"contacts":162},"SMG-SNU Boramae Medical Center","07061",{"type":52,"coordinates":160},[148,149],{"lat":149,"lon":148},[163,166],{"name":164,"role":37,"phone":26,"phoneExt":26,"email":165},"Ji Won Kim, M.D., Ph.D.","kjwjor@snu.ac.kr",{"name":164,"role":62,"phone":26,"phoneExt":26,"email":26},{"facility":168,"status":169,"city":144,"state":26,"zip":26,"country":50,"countryCode":26,"cosmosGeoPoint":170,"geoPoint":172,"contacts":173},"Asan Medical Center","NOT_YET_RECRUITING",{"type":52,"coordinates":171},[148,149],{"lat":149,"lon":148},[174],{"name":175,"role":37,"phone":26,"phoneExt":26,"email":176},"Jeong Hoon Lee, M.D., Ph.D.","jhlee.gi@amc.seoul.kr",{"type":62,"investigatorFullName":178,"investigatorTitle":179,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Il Ju Choi","Gastroenterologist",[181,183,185,186,187,188,190,192,194,195,197,199],{"name":129,"class":182},"UNKNOWN",{"name":64,"class":184},"OTHER",{"name":46,"class":184},{"name":157,"class":184},{"name":115,"class":184},{"name":189,"class":184},"Chung-Ang University Hosptial, Chung-Ang University College of Medicine",{"name":191,"class":182},"Chilgok Kyungpook National University",{"name":193,"class":184},"Hallym University Medical Center",{"name":168,"class":184},{"name":196,"class":184},"Seoul National University Bundang Hospital",{"name":198,"class":184},"Severance Hospital",{"name":200,"class":184},"Samsung Medical Center","100379010","phase-3-aspirin-use-for-gastric-cancer-prevention-in-the-early-gastric-cancer-patients-100379010",false,"NCT04214990","Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients","Effect of Low-dose Aspirin for Stomach Cancer Prevention After Endoscopic Resection of Gastric Neoplasm (EASTERN): a Randomized Controlled Trial","EASTERN","Inclusion Criteria:\n\n* Men and women aged 19-70 years who underwent endoscopic resection for high-grade adenoma or early gastric cancer (category 4 \\[non-invasive high grade neoplasm\\] or category 5 \\[invasive neoplasia\\] according to the Vienna classification of gastrointestinal epithelial neoplasia \\[Schlemper RJ, et al. Gut 2000;47:251-255.\\])\n* Final pathological results after endoscopic resection met the absolute or expanded criteria according to the Japanese Gastric Cancer Treatment guideline 2014 (version 4)\n* Patients who had negative H. pylori status or those who eradicated H. pylori status\n* Willingness to sign an informed consent form\n\nExclusion Criteria:\n\n* Patients who received aspirin for the secondary prevention of cardiovascular diseases or cerebrovascular diseases\n* Regular aspirin uses (more than 3 times a week) with 2 months before screening visit\n* Patients who used anticoagulants or antiplatelet drugs for therapeutic purpose\n* Previous gastrectomy history\n* Current treatment for serious medical condition which could hinder participation (such as severe heart dysfunction, liver cirrhosis, renal failure, COPD or bronchial asthma, or uncontrolled infection)\n* High risk patients for bleeding complications (cerebral aneurysm, vascular malformation, esophageal or gastric varices, or hemophilia, etc)\n* Active peptic ulcer disease (patients who treated peptic ulcer completely could be enrolled)\n* Diagnosis and active treatment for other organ cancer (except carcinoma in situ, and non-melanoma skin cancer) within 5 years\n* Non-curative resection of early gastric cancer after endoscopic resection\n* Aspirin allergy or contraindication of aspirin use\n* Pregnant or lactating women\n* Alcoholism, drug abuse\n* Inadequate patients for study enrollment according to the evaluation of the study physician\n* Inability to provide an informed consent\n* Patients who took a 28-day run-in-period medication less than 80%","ALL","19 Years","70 Years",{"count":213,"type":214},1700,"ESTIMATED","INTERVENTIONAL",[217],"PHASE3","This study aimed to investigate the effect of low-dose (100 mg) asprin on the prevention of gastric cancer in the early gastric cancer patients with negative H. pylori status who underwent endoscopic submucosal dissection.",[9,220],"Gastric Cancer",[9,222,223],"Gastric cancer prevention","Endoscopic submucosal dissection","2024-12-25",{"date":226,"type":227},"2024-12-27","ACTUAL",{"date":229,"type":227},"2020-02-15",{"date":231,"type":214},"2032-03-31",{"name":5,"class":6},10]